COLOPLAST NORGE AS

Coloplast Norge

Coloplast - leverandør av stomi og kontinensprodukter. Les om våre nyheter og få tips til en enklere hverdag.,Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions to meet their individual, personal needs. We call this intimate healthcare.

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO: RM
Reidar Mathisen1964
Chairman of the board: HR
Henning Reichardt1968
Years since formation: 30 years; since Mar 12, 1995
Type: Limited company
VAT registered: Yes
Number of employees: 36

Ownership

Number of shares and share classes: 10; 1 share class
Total number of shareholders: 1; person

Financials

Total operating income 2023: 433,398,225; NOK
Annual total result 2023: 31,840,536; NOK
Total equity 2023: 12,104,797; NOK

Last update: Dec 31, 2024

Management

Management / administration

Name	Role	Shares
RM Reidar Mathisen 1964	Managing Director/CEO	-

Board

Name	Role	Shares
HR Henning Reichardt 1968	Chairman	-
HD Henrik Deneke 1967	Board Member	-
HV Hea Vinskov 1977 Resigned	Board Member	-

Others

Name	Role	Shares
E ERNST & YOUNG AS	Auditor	-
S SPAREBANK 1 FORRETNINGSPARTNER ØSTLANDET AS	Accountant	-

Last update: Nov 5, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
DC Danmark As Coloplast	Ordinary shares	10	100 %

Last update: May 24, 2024

Financials

in NOK

Summary

Year	2022	2021
Total operating income	433,398,225	415,098,670
Annual Total Result	31,840,536	26,713,878
Total assets	89,039,215	91,832,258
Total liabilities	76,934,418	85,575,972
Total equity	12,104,797	6,256,286

P&L

Year	2022	2021
Total operating income	433,398,225	415,098,670
Total operating costs	393,369,168	380,253,882
Operating result	40,029,057	34,844,788
Financial income/costs	945,626	-397,005
Profit before tax	40,974,683	34,447,783
Total tax & extraordinary income/cost	9,134,147	7,733,905
Annual Total Result	31,840,536	26,713,878

Balance overview

Year	2022	2021
Total fixed assets	2,835,770	1,585,500
Total current assets	86,203,445	90,246,758
Total assets	89,039,215	91,832,258
Short term debt	76,934,418	85,575,972
Long term debt	0	0
Total liabilities	76,934,418	85,575,972
Contributed capital	12,104,797	500,000
Retained earnings	0	5,756,286
Total equity	12,104,797	6,256,286
Total equity and liabilities	89,039,215	91,832,258

COLOPLAST NORGE AS931 925 822